Exscientia lands blockbuster funding

Delighted to see portfolio company Exscientia close a funding of up to $525m as it continues to progress, in a round led by Softbank Vision Fund 2. In my view Exscientia is establishing itself as one of the clear leaders globally in the AI drug discovery space, which itself is central to more rapid and cost effective introduction of pharmaceuticals.